- Home
- EDIT vs ARKO Comparison
EDIT vs ARKO Comparison
Compare EDIT & ARKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EDIT | ARKO |
|---|---|---|
| Founded | 2013 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.8M | 490.3M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EDIT | ARKO |
|---|---|---|
| Price | $3.08 | $4.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $5.30 | ★ $7.50 |
| AVG Volume (30 Days) | ★ 2.6M | 1.2M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | ★ 37.50 | 15.38 |
| EPS | N/A | ★ N/A |
| Revenue | $31,937,000.00 | ★ $9,142,799,000.00 |
| Revenue This Year | N/A | $12.86 |
| Revenue Next Year | N/A | $1.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 132.64 | 23.26 |
| 52 Week Low | $1.66 | $3.71 |
| 52 Week High | $4.54 | $8.76 |
Technical Indicators
Market Signals| Indicator | EDIT | ARKO |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 36.34 |
| Support Level | $2.67 | $4.20 |
| Resistance Level | $3.21 | $5.26 |
| Average True Range (ATR) | 0.23 | 0.19 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 39.60 | 65.19 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. It derives the majority of its revenue from retail and wholesale distribution of fuel.